Pharmarise Holdings Corporation (2796) Stock Price

Pharmarise Holdings Co., Ltd. is a holding company that operates a network of dispensing pharmacies as its core business, while expanding into healthcare, long-term care, and related services. The company's primary services include dispensing medications based on prescriptions from medical institutions to general patients, as well as providing face-to-face medication counseling and pharmaceutical consultations.

The company's main customers are medical institutions and individual patients. Revenue is centered on dispensing fees from pharmacy operations and sales of pharmaceuticals and daily necessities. In addition to store-based sales, the company operates multiple revenue streams including cosmetics sales, convenience stores and drugstore operations, medical records storage and management, and home care and long-term care services.

The business is divided into five segments: dispensing pharmacy operations, retail sales, medical records storage and management, medical mall operations, and other healthcare-related services. Through multiple subsidiaries, the company operates pharmacy networks and engages in cosmetics sales, paper medical record and X-ray film storage, operation of a medical mall inside Sapporo Station, healthcare IT services, personnel dispatch and job placement, visiting nursing care, and senior care facility operations. The company pursues revenue growth by leveraging synergies with its core pharmacy business.

The company has adopted "Make a Leap 2027" as its medium-term management plan, aiming to establish itself as a preferred pharmacy group in its regions. For the final fiscal year ending May 2028, the company targets consolidated sales of 70 billion yen, operating profit of 1.6 billion yen, net income of 700 million yen, and a return on invested capital (ROIC) of 4.5%. Future growth will be achieved through realistic expansion of its existing business base. The company is avoiding excessive reliance on acquisitions and is prioritizing internal organizational development and strengthening its earnings foundation.

The company is focusing investment on enhancing pharmacist capabilities and improving store operations quality, allocating resources to education programs and leadership development. The company views individual pharmacists serving as trusted healthcare partners for patients as its key competitive differentiator. It aims to build competitive advantages through improved patient satisfaction measurement and enhancement, and by integrating home healthcare and elderly care services. Additionally, the company emphasizes investment in safety and trust, including establishing stable supply systems for generic drugs, implementing committees to prevent dispensing errors, and strengthening personal information management.

For business expansion, the company prioritizes the early integration (post-merger integration, or PMI) of recently acquired companies and stores, with plans to improve profit margins and operational efficiency before moving to scale expansion. Rather than relying unconditionally on acquisitions, the company is first solidifying its earnings base through cost reduction via consolidation of headquarters functions and systematization of financial management. It then plans to restructure and expand existing related businesses—including retail merchandise, medical mall operations, visiting nursing and care services, and healthcare staffing and IT—to generate synergies with its pharmacy business and boost profitability.

For technological innovation, the company is strengthening its digital transformation organizational structure by upgrading the DX promotion division and collaborating with its in-house system development company. It is responding to healthcare digitalization through online pharmaceutical counseling, online eligibility verification, and electronic prescription operations. By advancing automation and systematization of store and headquarters operations, the company aims to reduce operational costs while strengthening cybersecurity measures to ensure safety, thereby building the next-generation pharmacy model.